| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/26/2001 | WO2001052876A1 Ophthalmic compositions for treating ocular hypertension |
| 07/26/2001 | WO2001052866A1 Dextrin containing compositions for prevention of adhesions |
| 07/26/2001 | WO2001052859A1 Pharmaceutical parenteral composition containing a biphosphonate |
| 07/26/2001 | WO2001052842A1 Compositions for the prevention of diaper dermatitis |
| 07/26/2001 | WO2001052838A1 Purifying polyoxyethylated castor oils with activated charcoal and pharmaceutical formulations thereof |
| 07/26/2001 | WO2001052833A1 Compositions for delivery of a cortisol antagonist |
| 07/26/2001 | WO2001052826A2 Novel podophyllotoxin compositions |
| 07/26/2001 | WO2001052821A1 Improved pharmaceutical formulations |
| 07/26/2001 | WO2001052820A1 Bubbling tablet, bubbling bath additive tablet, bubbling washing detergent tablet, bubbling tablet for oral administration, and processes for producing these |
| 07/26/2001 | WO2001052817A2 Cochleate formulations and their use for delivering biologically relevant molecules |
| 07/26/2001 | WO2001052816A2 Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same |
| 07/26/2001 | WO2001052812A1 Diclofenamide suspension gel |
| 07/26/2001 | WO2001052743A1 Tunable indocyanine dyes for biomedical applications |
| 07/26/2001 | WO2001052664A1 Immune modulation with death receptor-induced apoptosis |
| 07/26/2001 | WO2001034206A8 Nucleic acid-containing complex |
| 07/26/2001 | WO2001015726A3 Compositions for stimulating cytokine secretion and inducing an immune response |
| 07/26/2001 | WO2001013891A3 Modulation of release from dry powder formulations |
| 07/26/2001 | WO2001007058A3 Parenteral cisplatin emulsion |
| 07/26/2001 | WO2001005372A3 A liposome composition having resistance to freeze/thaw damage |
| 07/26/2001 | WO2001001966A3 Sustained release dosage form unit having latex coating and method of making the same |
| 07/26/2001 | WO2000070341A3 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer |
| 07/26/2001 | WO2000069915A3 COMBINED APPROACH TO TREATMENT OF CANCER WITH hCG VACCINES |
| 07/26/2001 | WO2000059547A3 Method of detecting endometriosis |
| 07/26/2001 | WO2000056342A3 Use of stabilised oligonucleotides for preparing a medicine with antitumour activity |
| 07/26/2001 | WO2000049990A3 The process for manufacturing topical ophthalmic preparations without systemic effects |
| 07/26/2001 | WO2000044356A9 Hydrogel compositions useful for the sustained release of macromolecules and methods of making same |
| 07/26/2001 | WO2000040616A9 METHODS OF ELICITING BROADLY NEUTRALIZING ANTIBODIES TARGETING HIV-1 gp41 |
| 07/26/2001 | US20010009961 The reaction product of an alkali cellulose with a hydroxypropylating agent is granulated and the resulting granular material is neutralized with acid |
| 07/26/2001 | US20010009769 Polyhydroxyalkanoates for in vivo applications |
| 07/26/2001 | US20010009679 Fat soluble vitamin dispersed in a matrix of an emulsion-forming natural polysaccharide gum and/or a protein; beverages, tablets, cosmetics; powder in form of nanoparticles |
| 07/26/2001 | US20010009677 Sterol esters in tableted solid dosage forms |
| 07/26/2001 | US20010009663 Non-lethal methods for conditioning a recipient for bone marrow transplantation |
| 07/26/2001 | US20010009661 Preparing an iodine demand disinfectant by contacting at high temperature and pressure a porous strong base anion exchange resin in salt form with iodine or polyiodide ion absorbable by the resin to form the polyiodide-resin |
| 07/26/2001 | US20010009656 For treating solid mass tumors via catheter delivery, comprising a biocompatible polymer, a biocompatible solvent and a water insoluble radioisotope of given radioactive content |
| 07/26/2001 | DE10100779A1 Formulierung Formulation |
| 07/26/2001 | DE10001172A1 Templatieren von Feststoffpartikeln mit Polymermultischichten Templating of solid particles with polymer multilayers |
| 07/26/2001 | CA2398695A1 Chondromodulin-i related peptide |
| 07/26/2001 | CA2398102A1 Compounds and methods for prevention and treatment of her-2/neu associated malignancies |
| 07/26/2001 | CA2398086A1 Composition consisting of an active ingredient and a therapeutically active delivery system, especially in the treatment of angiogenesis |
| 07/26/2001 | CA2398010A1 An in vivo screen using chemical inducers of dimerization |
| 07/26/2001 | CA2397871A1 Novel podophyllotoxin compositions |
| 07/26/2001 | CA2397848A1 Purifying polyoxyethylated castor oils with activated charcoal and pharmaceutical formulations thereof |
| 07/26/2001 | CA2397833A1 Novel haptotactic peptides |
| 07/26/2001 | CA2397830A1 Compositions for the prevention of diaper dermatitis |
| 07/26/2001 | CA2397792A1 Cochleate formulations and their use for delivering biologically relevant molecules |
| 07/26/2001 | CA2397781A1 Compositions with enhanced oral bioavailability |
| 07/26/2001 | CA2397729A1 Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this method |
| 07/26/2001 | CA2397492A1 Method for nucleic acid transfection of cells |
| 07/26/2001 | CA2397490A1 Effervescent tablet, effervescent tablet for bath agent, effervescent tablet for washing detergent, effervescent tablet for oral administration and production methods thereof |
| 07/26/2001 | CA2397065A1 Compositions for delivery of a cortisol antagonist |
| 07/26/2001 | CA2396979A1 Immune modulation with death receptor-induced apoptosis |
| 07/26/2001 | CA2396381A1 Nasally administrable cyclic peptide compositions |
| 07/26/2001 | CA2396319A1 Ophthalmic compositions for treating ocular hypertension |
| 07/26/2001 | CA2394612A1 Antimicrobial compositions |
| 07/25/2001 | EP1118336A2 Somatostatin analogs to specific delivery of anti-tumor drugs into tumor cells |
| 07/25/2001 | EP1118335A1 Method for the production of conjugates for the treatment of allergic reactions and autoimmune diseases |
| 07/25/2001 | EP1118334A1 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 07/25/2001 | EP1118333A1 Compositions with enhanced oral bioavailability |
| 07/25/2001 | EP1118331A1 Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this method |
| 07/25/2001 | EP1117835A1 Prevention of adhesions |
| 07/25/2001 | EP1117726A1 Urethane(meth)acrylates containing siloxane groups and able to undergo free-radical polymerisation |
| 07/25/2001 | EP1117720A1 Polyester analogue of poly-l-lysine as a soluble, biodegradable gene delivery carrier |
| 07/25/2001 | EP1117696A1 Method for producing powder-shaped cross-linked polymerizates |
| 07/25/2001 | EP1117695A1 Biocompatible polymers, preparation method and compositions containing same |
| 07/25/2001 | EP1117444A2 Hydrogels and water soluble polymeric carriers for drug delivery |
| 07/25/2001 | EP1117443A1 Peptide-based carrier devices for stellate cells |
| 07/25/2001 | EP1117442A1 Dry powder active agent pulmonary delivery |
| 07/25/2001 | EP1117441A2 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them |
| 07/25/2001 | EP1117440A1 Pharmaceutical compositions containing paclitaxel |
| 07/25/2001 | EP1117439A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 07/25/2001 | EP1117420A1 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues |
| 07/25/2001 | EP1117412A1 Compositions containing diphosphonic acids |
| 07/25/2001 | EP1117411A1 Process for the preparation of oral pharmaceutical compositions comprising biphosphonates |
| 07/25/2001 | EP1117407A1 Oral dosage formulations comprising (2s, 3s,5r)-2-(3,5-difluorophenyl) -3,5-dimethyl-2-morpholinol and an effective stabilizing amount of alginic acid |
| 07/25/2001 | EP1117395A1 Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same |
| 07/25/2001 | EP1117390A1 Mucosal originated drug delivery systems and animal applications |
| 07/25/2001 | EP1117389A1 Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs |
| 07/25/2001 | EP1117387A2 Coated medicament forms with controlled active substance release |
| 07/25/2001 | EP1117386A1 Enteric and colonic delivery using hpmc capsules |
| 07/25/2001 | EP1117385A1 Aqueous enteric coating composition with low gastric permeability |
| 07/25/2001 | EP1117384A1 Controlled release nanoparticulate compositions |
| 07/25/2001 | EP1117383A1 Dosage form comprising therapeutic formulation |
| 07/25/2001 | EP1117382A1 Spray coated microparticles for use in needleless syringes |
| 07/25/2001 | EP1117381A1 Calcium phosphate delivery vehicle and adjuvant |
| 07/25/2001 | EP1117380A1 Glucoside paucilamellar vesicles |
| 07/25/2001 | EP1117379A1 Foamable formulation and foam |
| 07/25/2001 | EP1117378A2 Compositions and methods for enhancing receptor-mediated cellular internalization |
| 07/25/2001 | EP1117370A1 CONTROLLED RELEASE FROM COPOLYMERS OF ACRYLIC OR METHACRYLIC ACID/L-DOPA, ACRYLIC OR METHACRYLIC ACID/L-$g(a)-METHYL DOPA, ACRYLIC OR METHACRYLIC ACID/CARBIDOPA AND THEIR COMBINATIONS |
| 07/25/2001 | EP1117357A1 Methods and apparatus for improved administration of pharmaceutically active compounds |
| 07/25/2001 | EP1117355A1 Targeted therapy to a biomedical device |
| 07/25/2001 | EP1117351A2 Drug delivery systems |
| 07/25/2001 | EP0830126B1 Stabilized pseudo-emulsions and their preparation process |
| 07/25/2001 | EP0782440B1 Injection-molded dosage form |
| 07/25/2001 | EP0767656B1 Lipid based composition containing diacylglycerol, phospholipid, polar liquid and biologically active material |
| 07/25/2001 | EP0739206B1 Composition for drug delivery comprising nicotine or a derivative thereof and starch microspheres and method for the manufacturing thereof |
| 07/25/2001 | EP0726778B1 Oral delivery system of chemically modified proteins g-csf |
| 07/25/2001 | EP0722338B1 Protein- or peptide-cochleate vaccines and methods of immunizing using the same |
| 07/25/2001 | EP0674525B1 Aqueous pharmaceutical preparations of g-csf with a long shelf life |
| 07/25/2001 | EP0649312B1 Anthracycline conjugates, their preparation and their use as antitumor agents |
| 07/25/2001 | EP0585252B1 Pharmaceutical formulations |